BETA-OXIDATION OF VALPROIC ACID .1. EFFECTS OF FASTING AND GLUCOSE IN HUMANS

被引:27
作者
KOCH, KM [1 ]
WILENSKY, AJ [1 ]
LEVY, RH [1 ]
机构
[1] UNIV WASHINGTON,DEPT PHARMACEUT & NEUROL SURG,SEATTLE,WA 98195
关键词
D O I
10.1111/j.1528-1157.1989.tb05338.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:782 / 789
页数:8
相关论文
共 45 条
[1]   IDENTIFICATION OF VALPROIC ACID METABOLITES IN HUMAN-SERUM AND URINE USING HEXADEUTERATED VALPROIC ACID AND GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC ANALYSIS [J].
ACHEAMPONG, A ;
ABBOTT, F ;
BURTON, R .
BIOMEDICAL MASS SPECTROMETRY, 1983, 10 (11) :586-595
[3]   NUTRITION AND OXIDATIVE DRUG-METABOLISM IN MAN - RELATIVE INFLUENCE OF DIETARY LIPIDS, CARBOHYDRATE, AND PROTEIN [J].
ANDERSON, KE ;
CONNEY, AH ;
KAPPAS, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :493-501
[4]  
ANDERSON KE, 1982, NUTR REV, V40, P161, DOI 10.1111/j.1753-4887.1982.tb05298.x
[5]   INFLUENCE OF VALPROIC ACID ON HEPATIC CARBOHYDRATE AND LIPID-METABOLISM [J].
BECKER, CM ;
HARRIS, RA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1983, 223 (02) :381-392
[6]   INHIBITION OF MEDIUM-CHAIN FATTY-ACID BETA-OXIDATION INVITRO BY VALPROIC ACID AND ITS UNSATURATED METABOLITE, 2-NORMAL-PROPYL-4-PENTENOIC ACID [J].
BJORGE, SM ;
BAILLIE, TA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 132 (01) :245-252
[7]   THE INFLUENCE OF FREE FATTY-ACIDS ON VALPROIC ACID PLASMA-PROTEIN BINDING DURING FASTING IN NORMAL HUMANS [J].
BOWDLE, TA ;
PATEL, IH ;
LEVY, RH ;
WILENSKY, AJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 23 (04) :343-347
[8]   ACTION OF THE ANTI-EPILEPTIC DRUG, VALPROIC ACID, ON FATTY-ACID OXIDATION IN ISOLATED RAT HEPATOCYTES [J].
COUDE, FX ;
GRIMBER, G ;
PELET, A ;
BENOIT, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 115 (02) :730-736
[9]   REARRANGEMENT OF VALPROATE GLUCURONIDE IN A PATIENT WITH DRUG-ASSOCIATED HEPATOBILIARY AND RENAL DYSFUNCTION [J].
DICKINSON, RG ;
KLUCK, RM ;
HOOPER, WD ;
PATTERSON, M ;
CHALK, JB ;
EADIE, MJ .
EPILEPSIA, 1985, 26 (06) :589-593
[10]  
DICKINSON RG, 1984, DRUG METAB DISPOS, V12, P247